HTA91 5 Years of CAR-T Cell Therapies—Comparison of German AMNOG Dossiers in Terms of Available Evidence and Price Development
Abstract
Authors
J. Drews K. Blondrath I. Ernst T. Wiest S. Wohlmuther D. Bonduelle
J. Drews K. Blondrath I. Ernst T. Wiest S. Wohlmuther D. Bonduelle
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now